文献速递胸部肿瘤

基于风险的肺癌筛查对曼彻斯特晚期肺癌发病率的人群影响

Population Impact of Risk-Based Lung Cancer Screening on Late-Stage Incidence in Greater Manchester.
PubMed 文献 · J Thorac Oncol · 2025-12-02

该研究在大曼彻斯特社会经济贫困地区比较实施社区肺癌筛查区域与四个未筛查邻区,55至80岁受邀人群晚期肺癌发病率在筛查实施后下降更陡,校正发病率比为0.78(95%CI 0.62-0.99,p=0.037),对应晚期肺癌发病率降低22%。针对性低剂量CT筛查覆盖全人群2.0%(4468/221240),检出筛查启动以来全部肺癌的31%(221/722),每检出1例肺癌需筛查20人。

要点

  • 社区肺癌筛查与55至80岁受邀人群晚期肺癌发病率降低22%相关(校正IRR 0.78,95%CI 0.62-0.99,p=0.037)。
  • 筛查覆盖全人群2.0%(4468/221240),检出全部肺癌的31%(221/722)。
  • 每检出1例肺癌需筛查人数为20。

核心结论

  • 在社会经济高度贫困地区实施针对性社区肺癌筛查与晚期肺癌发病率显著降低相关,展示了筛查有效性和公共卫生获益。

研究设计与样本

  • 比较筛查实施前后,筛查区(北与东曼彻斯特)与四个未筛查邻区55至80岁受邀人群的晚期肺癌发病率,采用双重差分模型估计筛查效应。

主要发现

  • 筛查区晚期肺癌发病率下降更陡,筛查与55至80岁受邀人群晚期肺癌发病率降低22%相关(校正发病率比0.78,95%CI 0.62-0.99,p=0.037)。
  • 针对性低剂量CT筛查覆盖全北与东曼彻斯特人群的2.0%(4468/221240),检出筛查启动以来全部肺癌的31%(221/722)。
  • 每检出1例肺癌的需筛查人数为20。

关键数值与推荐

  • 筛查对象为受邀时年龄55至80岁个体。
  • 针对性低剂量CT筛查覆盖全人群2.0%(4468/221240)。
  • 筛查检出全部肺癌的31%(221/722),每检出1例肺癌需筛查20人。

临床怎么用

  • 在贫困地区可考虑实施针对性社区肺癌筛查以降低晚期肺癌发病率。
  • 筛查项目规划可参考受邀年龄55至80岁及约2.0%人群覆盖的针对性低剂量CT策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Low-dose computed tomography screening reduces lung cancer mortality in clinical trials, but evidence of impact in real-world programs is lacking. Here, we evaluate the impact of screening in a socio-economically deprived area at the population level. We hypothesized that late-stage lung cancer incidence, as a surrogate for lung cancer mortality, would decrease after systematic implementation of screening in a high-risk population. METHODS: Late-stage lung cancer incidence among individuals aged 55 to 80 years at the time of screening invitation was compared before and after screening implementation between regions with and without implementation of community-based lung cancer screening (North & East Manchester [screening] versus four neighboring regions [no screening]). The effect of screening was estimated using difference-in-difference modeling. RESULTS: Late-stage lung cancer incidence decreased more steeply in the screening region, such that screening was associated with a 22% reduction in late-stage lung cancer incidence among the invited age range of 55 to 80 years (adjusted incidence rate ratio, 0.78; 95% confidence interval, 0.62-0.99; p = 0.037). Targeted low-dose computed tomography screening of 2.0% of the full North & East Manchester population (n = 4468/221,240) detected 31% of all lung cancers diagnosed since screening commenced (n = 221/722), yielding a number-needed-to-screen of 20 for each cancer detected. CONCLUSION: Implementation of targeted, community-based lung cancer screening in an area of high socioeconomic deprivation was associated with a significant reduction in late-stage lung cancer incidence. This provides a demonstration of screening effectiveness and public health benefit.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Goodley P, Balata H, Alonso A, et al. Population Impact of Risk-Based Lung Cancer Screening on Late-Stage Incidence in Greater Manchester. J Thorac Oncol. 2025. PMID: 41344502. doi:10.1016/j.jtho.2025.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。